Bipolar left ventricular pacing is associated with significant reduction in heart failure or death in CRT-D patients

Sina Jamé1, Valentina Kutyifa2, Mehmet K Aktas2

  • 1Stanford University, Stanford, California.

Heart Rhythm
|March 11, 2016
PubMed

Insights

True Bipolar left ventricular lead pacing significantly reduces mortality and heart failure events in patients with left bundle branch block receiving cardiac resynchronization therapy with a defibrillator. This finding offers crucial insights for optimizing CRT-D device programming.

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Outcomes

Background:

  • Limited data exist on the predictive value of left ventricular (LV) lead pacing polarity for clinical outcomes.
  • Understanding these associations is crucial for optimizing cardiac resynchronization therapy (CRT) device performance.

Purpose of the Study:

  • To determine if LV lead pacing polarity influences heart failure (HF) or death risk.
  • To assess the association between LV pacing polarity and ventricular tachyarrhythmias (VTA) in CRT-D patients.

Main Methods:

  • Retrospective analysis of LV pacing polarity in 969 patients from the MADIT-CRT trial.
  • Categorization into True Bipolar (LV ring/tip) and Unipolar/Extended Bipolar pacing configurations.
  • Kaplan-Meier analysis and Cox regression models to evaluate outcomes.

Main Results:

  • True Bipolar pacing was observed in 421 patients; Unipolar/Extended Bipolar in 548.
  • In patients with left bundle branch block (LBBB), True Bipolar pacing correlated with lower death (P=.022) and HF/death (P=.046) incidence.
  • Adjusted analysis showed True Bipolar pacing reduced death risk by 54% (HR 0.46) and HF/death by 32% (HR 0.68) in LBBB patients, but not in non-LBBB patients. No VTA association was found.

Conclusions:

  • True Bipolar LV pacing configuration is linked to significantly lower HF/death and all-cause mortality in CRT-D patients with LBBB.
  • This suggests a potential benefit of specific LV lead configurations for patient outcomes in this population.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
616
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
907
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.5K